By now, you should know the truly big stories in the mobile sector: Samsung’s rise to challenge Apple, Microsoft finally acquiring Nokia, Google leaping into wearables, more moves toward carrier consolidation. But if you want to get a jump start on some of the biggest trends shaping up in the mobile industry, you could do … Continue reading “Here’s What Mobile Industry Insiders See Ahead for 2014”
Category: Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise
When Dicerna Pharmaceuticals hauled in $60 million back in August, CEO Doug Fambrough hinted that an IPO was on the way. The Watertown, MA-based company made good on that prediction this morning. Dicerna has filed papers with the Securities and Exchange Commission outlining plans to raise up to $69 million from public investors through an … Continue reading “Dicerna Joins Biotech IPO Queue, Plans $69M Raise”
Tech Bubble Leaks Air, Healthcare Bests Biotech, & More for 2014
The coming year will see some good news and some bad news in tech. Here are five predictions. • IPOs: This past year witnessed an extraordinary resurgence in IPO activity for venture-backed companies. It felt much like 1999 right before the crest of the wave. With modest growth, unsustainably high valuation multiples, little excess left for … Continue reading “Tech Bubble Leaks Air, Healthcare Bests Biotech, & More for 2014”
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche”
For the better part of a year, Scholar Rock has worked behind the scenes mapping out an approach to hit well-known disease targets in an unusual way. Now, the nascent Cambridge, MA-based startup is ready to discuss what it’s found. Scholar Rock is emerging from stealth mode today to make two announcements: First, it’s licensed … Continue reading “Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche””
The Year in Innovation: Xconomy’s Top 13 Stories of 2013
If you only have time to read a few of our articles from the past year, these are the ones. These are editor’s picks (mine). They are not based on Web traffic, but rather on a subjective weighting of their impact, significance, and representation of our mission and geographies. Xconomy is now in 9 regions … Continue reading “The Year in Innovation: Xconomy’s Top 13 Stories of 2013”
Remembering James L. Vincent, Longtime Biogen Leader
Are they making innovators quite like James L. Vincent any more? This question, spurred by Vincent’s death on Dec. 5, has more edge these days as we worry how Americans are going to keep inventing, making, and selling new things to earn a good living in a sharply competitive world. More bluntly, do the innovators … Continue reading “Remembering James L. Vincent, Longtime Biogen Leader”
Help Wanted: Houston vs. Austin and the Search for the Best IT Talent
Last May, we announced that we were moving Datafiniti to Austin. A big reason for our move was the lack of a suitable talent pool from which to hire. There was a lot of skepticism—perhaps surprisingly so—around our reasoning. At the time, we provided what I thought was a healthy dose of data to back … Continue reading “Help Wanted: Houston vs. Austin and the Search for the Best IT Talent”
Reflexis Systems Secures $28,350,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=befc4316-0b20-4cbb-b5cd-6a2c45c18672 Date 12/31/2013 Company Name Reflexis Systems Mailing Address 3 Allied Drive Dedham, MA 02026 Company Description Reflexis helps major retailers turn strategy into action with the integrated RetailActions – a suite of next-generation Retail Execution Management solutions. Website http://www.reflexisinc.com Transaction Type Venture Equity Transaction Amount $28,350,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Reflexis Systems Secures $28,350,000 New Financing Round”
Verivo Software Lands $1,750,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c154b252-74c2-4f55-b06d-e4e8165f8620 Date 12/31/2013 Company Name Verivo Software Mailing Address 1000 Winter St. 2nd Floor Waltham, MA 02451 Company Description Today, our unique enterprise mobility platform is used by hundreds of companies in numerous industries – from life sciences and manufacturing to automotive and transportation. Website http://www.verivo.com Transaction Type Debt Transaction Amount $1,750,000 … Continue reading “Verivo Software Lands $1,750,000 New Financing”
NXT-ID Obtains $350,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d06356a4-9511-466e-87d1-3ce1e9a81f30 Date 12/31/2013 Company Name NXT-ID Mailing Address 4 Research Drive Shelton, CT 06484 Company Description The founders of NXT-ID were an integral part of the senior management teams at Technest Holdings, Inc., and its subsidiary Genex Technologies. Genex Technologies was founded in 1995 to develop and commercialize the unique Rainbow method … Continue reading “NXT-ID Obtains $350,000 New Funding”
Adapteva Garners $3,600,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4bcce90b-bdcf-4383-8791-7eac91998fce Date 12/31/2013 Company Name Adapteva Mailing Address 1666 Massachusetts Ave Lexington, MA 02420 Company Description Adapteva Inc. is a privately held fabless semiconductor company based in Lexington, Massachusetts that has developed the the world’s most energy efficient multicore microprocessors. Website http://www.adapteva.com Transaction Type Venture Equity Transaction Amount $3,600,000 Transaction Round Undisclosed … Continue reading “Adapteva Garners $3,600,000 New Financing”
Avigilon Acquires VideoIQ for $32,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9ac556d0-650d-4eb5-8037-6a396ca42210 Date 12/31/2013 Company Name VideoIQ Mailing Address 213 Burlington Road Bedford, MA 01730 Company Description VideoIQ acts as digital guard that transforms video surveillance into a dynamic, real-time, intelligent system for guarding against intruders, and gaining early warning of security breaches. It delivers the industry’s best detection accuracy and far fewer … Continue reading “Avigilon Acquires VideoIQ for $32,000,000”
Aras Secures $1,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c57b429f-026c-49e5-a75b-393909ca05b2 Date 12/31/2013 Company Name Aras Mailing Address 300 Brickstone Square Andover, MA 01810 Company Description Aras Corporation is a provider of enterprise Product Lifecycle Management (PLM) software. Aras Innovator(TM) is an engineering business application suite with comprehensive out-of-the-box functionality that addresses the rigorous requirements of discrete manufacturing operations for divisions of … Continue reading “Aras Secures $1,000,000 New Funding Round”
Why Angels Should Keep Their Distance from Crowdfunding in 2014
There’s certainly been a lot of uncertainty in the angel and venture capital arenas over the past decade, and understandably so. Add to that, the lure of crowdfunding—a nearly $3 billion business in 2012—and it’s led some angel groups to consider if there is a role for individual investors in crowdfunding their deals. My advice … Continue reading “Why Angels Should Keep Their Distance from Crowdfunding in 2014”
Xconomy Boston’s Top 10 Stories of Q4: Editor’s Picks
As 2013 draws to a close, let’s not short-change the events of the most recent quarter in our retrospective. A lot has happened in the Boston innovation scene since early October, and most of it was not commodity news. Here are my picks for 10 of the most compelling and representative stories in Xconomy Boston … Continue reading “Xconomy Boston’s Top 10 Stories of Q4: Editor’s Picks”
Why Business and Personal Email Are Not the Same
We all carry certain expectations about email from our private lives into a corporate setting. Some of those expectations are met, but in other ways business email is very different from consumer email. These differences can be confusing at best and, at worst, lead to major problems for organizations. The Inside and the Outside To … Continue reading “Why Business and Personal Email Are Not the Same”
NewForma Lands $50,000 Series D Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8fc7e1c1-102f-4a61-8b93-377548e720df Date 12/30/2013 Company Name NewForma Mailing Address 1750 Elm Street 10th Floor Manchester, NH 03104 Company Description Newforma Project Center project collaboration software makes managing the architectural and engineering building process easier. Website http://www.newforma.com Transaction Type Venture Equity Transaction Amount $50,000 Transaction Round Series D Proceeds Purposes Proceeds purposes were not … Continue reading “NewForma Lands $50,000 Series D Round”
GNS Healthcare Obtains $9,939,920 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e96874fb-c162-436d-b2ea-69990c910997 Date 12/30/2013 Company Name GNS Healthcare Mailing Address One Charles Park Cambridge, MA 02142 Company Description GNS Healthcare is a healthcare analytics company, founded in 2000 and based in Kendall Square, Cambridge, MA. We focus on advancing and applying industrial-scale data analytics to empower key healthcare stakeholders to solve complex care, … Continue reading “GNS Healthcare Obtains $9,939,920 New Financing Round”
Good, Business, and Good Business
Here in the 20-teens, the roles of for-profit businesses, non-profit organizations, government, NGO’s, foundations, investors and philanthropists are beginning to blur together. We are quickly finding ourselves in a world where it is not only possible to do good while doing business, but expected. This is quite a change from the “Friedman Doctrine” that claimed … Continue reading “Good, Business, and Good Business”
peerTransfer Secures $6,200,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06a49e99-ce90-44f5-90f1-0ad4bd31bf98 Date 12/27/2013 Company Name peerTransfer Mailing Address 295 Devonshire Street 4th Floor Boston, MA 02110 Company Description peerTransfer is the pioneer in low cost online international money transfer and global payments,helping individuals and businesses securely transfer funds internationally while saving money. Website http://www.peertransfer.com Transaction Type Venture Equity Transaction Amount $6,200,000 Transaction … Continue reading “peerTransfer Secures $6,200,000 New Round”
MC10 Lands $19,809,064 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=484fa5c1-38be-407f-86f4-b04d48a24b8f Date 12/27/2013 Company Name MC10 Mailing Address 9 Camp Street 2nd Floor Cambridge, MA 02140 Company Description We’re MC10. It’s our mission to extend human capabilities by making high-performance electronics virtually invisible, conformal, and wearable. We reshape rigid, conventional electronics into thin, flexible devices that can stretch, bend and twist seamlessly … Continue reading “MC10 Lands $19,809,064 New Financing Round”
4 Tech Trends That Will Impact Risk and Compliance Efforts in 2014
Once business organizations reach a certain size, their leaders have to start thinking systematically about how to structure reporting relationships to ensure vital information reaches the top; how to identify and account for the internal and external risks that could hobble the company; and how to ensure the organization is complying with a skein of … Continue reading “4 Tech Trends That Will Impact Risk and Compliance Efforts in 2014”
My Top Picks in Bio-Venture Innovations, and Predictions for 2014
I am a biotech VC, but not a techie. So I don’t follow stem cells, gene therapy, and other similar “blockbuster” technologies in the life sciences. Rather than looking at all the gosh-and-golly stuff going into the biotech pipeline, I wait to see what is coming out of the other end. So far, very little … Continue reading “My Top Picks in Bio-Venture Innovations, and Predictions for 2014”
We Ask the Xconomists: Some Quick Predictions for the New Year
As 2013 drew to a close, we asked some of our Xconomists to ponder innovation, past and future, and to give us their predictions for the breakout innovations they expect to see in their respective fields. Here’s what they had to say: Texas Xconomist Blair Garrou, managing director at Mercury Fund in Houston: I’m excited … Continue reading “We Ask the Xconomists: Some Quick Predictions for the New Year”
Moontoast Secures $1,758,463 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e24d6fa5-26d2-4912-aff8-8238cbaf655e Date 12/26/2013 Company Name Moontoast Mailing Address 300 Brickstone Square Andover, MA 01810 Company Description Moontoast is the leading Distributed Social Commerce Platform for Retailers, Publishers, Musicians and Celebrities. The Moontoast platform enables brands to engage, share, analyze and drive revenue from your fans and consumers directly within any site fans … Continue reading “Moontoast Secures $1,758,463 New Funding”
Blend Therapeutics Secures $5,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ea2bb10-ec35-4f9a-9b8c-8328156ceda6 Date 12/26/2013 Company Name Blend Therapeutics Mailing Address 134 Coolidge Avenue Watertown, MA 02472 Company Description Blend is pioneering controlled combination medicines that overcome the limitations of conventional combination therapy through their unprecedented ability to hit distinct disease pathways with multiple drugs in concert—at the desired sites, at the most effective … Continue reading “Blend Therapeutics Secures $5,000,000 New Financing Round”
iMedX Garners $4,034,263 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=edeac1fb-d022-42a8-a9f8-af39d1f98d13 Date 12/26/2013 Company Name iMedX Mailing Address 4 Corporate Drive Shelton, CT 06484 Company Description iMedX, Inc. is a rapidly growing medical software and services company headquartered in Shelton, Connecticut. The Company’s main product is TurboScribe, a unique combination of medical transcription software and service. Website http://www.imedx.com Transaction Type Venture Equity … Continue reading “iMedX Garners $4,034,263 New Financing”
Wymsee Secures $2,500,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35acea72-b63e-4d40-ac2e-20210ea9b5b5 Date 12/25/2013 Company Name Wymsee Mailing Address 1 Cambridge Center Cambridge, MA 02139 Company Description Sync OnSet is the first product of Wymsee, Inc., a young technology company based in Cambridge, MA. Our team is extremely passionate about the TV and film industries, and love making products to enhance the work … Continue reading “Wymsee Secures $2,500,000 Seed Financing”
Boston Roundup: GNS, DailyFeats, Wymsee, Moontoast, Where Angels
It wouldn’t be the holidays without a good old-fashioned news dump. Here’s a few deals that have popped up on the radar while most people are getting ready for a few days off: —GNS Healthcare, a “big data” healthcare company, has filed paperwork for a nearly $10 million equity fundraising. GNS has compiled a database … Continue reading “Boston Roundup: GNS, DailyFeats, Wymsee, Moontoast, Where Angels”
Observations From Korea’s Creative Economy 2013 Conference
Innovation is one of those goals that transcends borders. Spurring technology innovation, and through it the creation of new industries that accelerate job growth, is always high on the agenda of any advanced economy. But what if you had to change the culture of an entire nation at the same time? That’s a major part … Continue reading “Observations From Korea’s Creative Economy 2013 Conference”
A Need to Know: Adding DNA and Geomedicine Data to Patient Records
It takes a lot of patience to be a patient. There are about 1.2 billion physician office visits annually in the United States, according to the National Center for Health Statistics. The center, which has collected data on this subject for decades, also reports that patients wait an average of just “north” of 11 minutes … Continue reading “A Need to Know: Adding DNA and Geomedicine Data to Patient Records”
Age of Surprise
For about 500 years, it seems that we’ve been living in an era of permanent surprise, of unanticipated discoveries like Columbus’ landfall in what he thought was an outpost of China. Ever since, we have been conditioned to expect the unexpected. And around 1760, about halfway through our age, we entered the factory era that … Continue reading “Age of Surprise”
Mederi Therapeutics Lands $10,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d3ab127f-243f-45b4-b07e-e89edb63539c Date 12/24/2013 Company Name Mederi Therapeutics Mailing Address 8 Sound Shore Drive Greenwich, CT 06830 Company Description Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease. Mederi Therapeutics holds over 80 patents in the use of RF energy for treatment of disease states affecting the … Continue reading “Mederi Therapeutics Lands $10,000,000 New Funding Round”
Vaccine Developer Genocea Files For IPO, Plans to Raise $75M
Genocea Biosciences has spent years fine-tuning a platform that’s supposed to make it quicker and easier to produce a vaccine. Now, with its two first products in early development, it’ll see if public investors have taken to its progress. In filings with the SEC, Cambridge, MA-based Genocea said it plans to raise up to $75 … Continue reading “Vaccine Developer Genocea Files For IPO, Plans to Raise $75M”
General Catalyst Raises $675M, Wants to Grow Silicon Valley Office
Venture capital firm General Catalyst Partners has raised $675 million for its seventh investment fund, saying it wants to continue investing in fast-growing companies from coast to coast—with a special focus on Silicon Valley. The deal, announced today, comes about two years after General Catalyst raised $500 million for its sixth fund. The firm has invested … Continue reading “General Catalyst Raises $675M, Wants to Grow Silicon Valley Office”
Investors Sink Tesaro Shares on Phase 3 Misses For Cancer Drug
Waltham, MA-based Tesaro (NASDAQ: [[ticker:TSRO]]) is trumpeting some late-stage success for its lead cancer drug, rolapitant, but investors clearly aren’t buying the results. Tesaro this morning released the top-line data from two Phase III trials for rolapitant, a drug it’s developing for chemotherapy-induced nausea and vomiting (CINV). The company emphasized that rolapitant hit the primary … Continue reading “Investors Sink Tesaro Shares on Phase 3 Misses For Cancer Drug”
Diverse Software Developer Talent—A Gift That Keeps on Giving
Here’s a fresh take on the spirit of giving: Ten Washington technology companies have agreed to “pay it forward” by supporting Seattle’s first not-for-profit coding academy focused on preparing women who show technical aptitude, but have little or no technical experience, to become software developers. During the Technology Alliance’s early days in the mid-1990s, Washington … Continue reading “Diverse Software Developer Talent—A Gift That Keeps on Giving”
10 Tips for Maximizing the JP Morgan Healthcare Experience
San Francisco, we’re coming. Of course, you are ready for the biotech onslaught. The cab drivers, hotel people, cops, security dudes, restaurant and bar staff—you all know the drill come January. So what about all the healthcare industry capitalists? Are you ready to make the most of this week when all the decision makers and … Continue reading “10 Tips for Maximizing the JP Morgan Healthcare Experience”
Avaxia Biologics Secures $2,872,388 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e24f87f-4d19-4638-885a-2c9bb3010a30 Date 12/23/2013 Company Name Avaxia Biologics Mailing Address 128 Spring Street Lexington, MA 02421 Company Description Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract. Website http://www.avaxiabiologics.com Transaction Type Debt Transaction Amount $2,872,388 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Avaxia Biologics Secures $2,872,388 New Round”
GreenLight Biosciences Lands $1,045,815 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=76aec5d5-4b31-4859-86ca-e2ac7e4c0129 Date 12/23/2013 Company Name GreenLight Biosciences Mailing Address 200 Boston Avenue Medford, MA 02155 Company Description GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its Unconstrained Metabolism technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products … Continue reading “GreenLight Biosciences Lands $1,045,815 New Financing Round”
Ariad’s Cancer Drug to Return to U.S. in January, Shares Soar
It’s been a rough few months for Ariad Pharmaceuticals, but the Cambridge, MA-based company finally got some good news today. The FDA has given Ariad the green light to bring its cancer drug, ponatinib (Iclusig), back to the U.S. market in the middle of January. While that’s big news for Ariad—ponatinib is its only drug—it … Continue reading “Ariad’s Cancer Drug to Return to U.S. in January, Shares Soar”
News, Social Networking Meet in Prismatic’s “Interest Network”
Over the last 20 years, three new technologies have come together to reshape the way information enters our lives. First, of course, there was the Web, starting around 1993. Then came social networking, starting around 2003. And finally—hugely amplifying the effects of the first two—came broadband-capable smartphones and tablets, starting in 2007. Any one of … Continue reading “News, Social Networking Meet in Prismatic’s “Interest Network””
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More
Time to bid an adieu to 2013. Xconomy will go on a little holiday break once Christmas rolls around next week, so this’ll be the last roundup of the year. True to form in what’s been a wild year for biotech—the Nasdaq Biotechnology Index is up more than 50 percent since Jan. 2— it’s jam-packed. … Continue reading “East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More”
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed
Radius Health’s skin patch for osteoporosis appears to have fallen short of expectations in a mid-stage clinical trial, leading to a roughly two-year delay in development and what’s been a revolving door of four CEOs over the past month, Xconomy has learned. The Cambridge, MA-based company, which tried to go public last year, but ultimately … Continue reading “Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed”
7AC Technologies Lands $1,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7024fe5c-6dd9-428f-ab23-1e0f45434657 Date 12/20/2013 Company Name 7AC Technologies Mailing Address 100 Cummings Center Beverly, MA 01915 Company Description 7AC Technologies, Inc. develops revolutionary Ultra Efficient Liquid Desiccant HVAC systems for Commercial and Industrial (C&I) buildings delivering a 50%+ reduction in energy costs over conventional HVAC units. Website http://www.7actech.com Transaction Type Debt Transaction Amount … Continue reading “7AC Technologies Lands $1,000,000 New Funding Round”
SynDevRx Obtains $602,747 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=31c63510-466b-46a5-802e-5d67c805501d Date 12/20/2013 Company Name SynDevRx Mailing Address One Broadway 14th Floor Cambridge, MA 02142 Company Description Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit angiogenesis … Continue reading “SynDevRx Obtains $602,747 New Round”
Dealertrack Technologies Acquires Dealer.com for $992,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2577eb33-aaa6-4e1d-b44f-6e06e8929400 Date 12/20/2013 Company Name Dealer.com Mailing Address 1 Howard St. Burlington, VT 05401 Company Description Dealer.com is the global leader in online marketing solutions for the automotive industry, providing award winning e-marketing solutions to auto dealers, OEM’s and media companies. More dealerships use the Dealer.com platform than any other platform in … Continue reading “Dealertrack Technologies Acquires Dealer.com for $992,000,000”
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study
The results are out from Vertex Pharmaceuticals’ (NASDAQ: [[ticker:VRTX]]) latest cystic fibrosis study. And while the Cambridge, MA-based company didn’t get what it was looking for, it still says the numbers are good enough to bring to the FDA next year. Vertex announced the results of a late-stage study testing its cystic fibrosis drug, ivacaftor … Continue reading “Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study”
Paragonix Technologies Garners $1,100,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06d67d8e-02b0-440e-8ffe-70f9f1dd0c51 Date 12/19/2013 Company Name Paragonix Technologies Mailing Address 639 Granite Street Braintree, MA 02184 Company Description Founded in 2010, Paragonix Technologies Inc., is a privately held medical device company innovating the Sherpa Cardiac Transport System, a novel, single-use organ preservation device to improve donor organ quality and extend donor organ preservation … Continue reading “Paragonix Technologies Garners $1,100,000 New Funding”
Curoverse Obtains $1,500,000 Seed Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c8438324-df01-4177-b91f-945a0e19c523 Date 12/19/2013 Company Name Curoverse Mailing Address 332 Congress Street 4th Floor Boston, MA 02210 Company Description Curoverse is entirely built with open source software. At its core, Curoverse uses a free and open source system called Arvados that was first developed for the Harvard Personal Genome Project. Arvados is designed … Continue reading “Curoverse Obtains $1,500,000 Seed Financing Round”